Canada had the best performing stock index in the developed world in 2016. The TSX (Toronto Stock Exchange) index delivered a total return of 18.26%. That was a 34% premium to the S&P 500’s total return of 13.59%. #-ad_banner-#This awesome performance was driven by a newly-listed TSX stock. On July 26, Canopy Growth Corp (TSX: WEED) became the first-ever cannabis company to be listed on the TSX Index. The listing generated huge interest from investors eager to cash in on the high-growth medical cannabis industry. Since the listing, shares of Canopy have gained 186%, making it the one of the… Read More
Canada had the best performing stock index in the developed world in 2016. The TSX (Toronto Stock Exchange) index delivered a total return of 18.26%. That was a 34% premium to the S&P 500’s total return of 13.59%. #-ad_banner-#This awesome performance was driven by a newly-listed TSX stock. On July 26, Canopy Growth Corp (TSX: WEED) became the first-ever cannabis company to be listed on the TSX Index. The listing generated huge interest from investors eager to cash in on the high-growth medical cannabis industry. Since the listing, shares of Canopy have gained 186%, making it the one of the best performing stocks on the entire TSX Index. I wrote about CGC on November 1, telling investors to pay attention. Since my article was published, Canopy is up 81%. If you missed out on those big returns, don’t worry. I see that same pattern unfolding again. Canopy is about to be joined on the TSX Index by another cannabis company. Aphria (TSXV: APH) is the second-largest medical cannabis company in Canada with a market value of $591 million. Shares of Aphria are currently traded on the Toronto Venture Stock Exchange, a subsidiary of the TSX that allows smaller companies to… Read More